LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens

We have previously shown that through the production of high LIGHT levels, immune cells contribute to both osteoclastogenesis and bone destruction in Multiple Myeloma (MM)-related bone disease. With the aim of further exploring the mechanisms underlying the development of MM-related bone disease, he...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Immunol
Hlavní autoři: Brunetti, Giacomina, Rizzi, Rita, Storlino, Giuseppina, Bortolotti, Sara, Colaianni, Graziana, Sanesi, Lorenzo, Lippo, Luciana, Faienza, Maria Felicia, Mestice, Anna, Curci, Paola, Specchia, Giorgina, Grano, Maria, Colucci, Silvia
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2018
Témata:
Immunology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6206078/
https://ncbi.nlm.nih.gov/pubmed/30405638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2018.02459
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky